Research indicates that back pain can double the risk of dementia in some adults

The pain reliever used to decrease back pain can be linked to an increased risk of dementia and mild cognitive weakness (MCI) New search.

The study, published on the Internet in the Journal of Regional Anesthesia and Pain, found that the groups that have already been considered younger than developing the conditions facing more than twice the risks when eating gabeinin.

“The results we found indicate that there is a relationship between the recipe of Gababin, dementia or cognitive weakness within 10 years,” the research team said in a press release.

The study found that breast cancer survivors may be less risk of Alzheimer’s disease

The researchers indicated in a press statement that the drug has become increasingly common to treat chronic pain, especially nerve pain (nerve).

GABAPENTIN – which is also used to control seizures, according to Cleveland Clinic – the addiction capabilities are relatively low compared to the mind Traditional opium materials.

Recent research has sparked new concerns about its side effects, including potential association with nervous degeneration.

The previous results cannot confirm a specific link, especially with regard to whether it is Certain age groups More at risk.

In the last study, the researchers collected data from Trinetx, a healthy research network containing electronic health records from 68 health care organizations throughout the United States

The research shows that more elderly people use cannabis more than ever despite the health risks.

Examine unknown records for adult patients, the team looked at the groups that Gabapentin described in the least chronic Back pain Between 2004 and 2024 and compared them to people who did not receive the medicine. There was a total of 2,6414 individuals in each group.

The researchers represented factors such as the population composition, the conditions that exist, and the use of other drugs that disappear the pain.

Patients who received six or more of the gababein recipes were 29 % more likely With dementia The study found that 85 % is more likely to diagnose MCI within 10 years of initial pain diagnosis.

Click here to get the Fox News app

Looking at the specific age groups, people between the ages of 18 and 64 were more than twice the medicine, which were likely to develop any of the two conditions from those who were not described by Gabapentin.

Click here to register in our health newsletter

While there was no growing danger between those between the ages of 18 and 34 PrescriptionThe risk of developing dementia is more than twice (and the risk of MCI is more than three times) between 35 to 49 children.

The researchers have noticed a similar pattern among children between the ages of 50 and 64.

The risks increased by the frequency of medical prescriptions: Patients with 12 prescriptions were 40 % more likely to develop dementia and more likely to develop MCI 65 % than those who described the japabethen between three and 11 times.

“The results we have found indicate that there is a correlation between the recipe for gabenein and dementia or cognitive weakness within 10 years.”

The study had some restrictions. As this was a note -based study, strong conclusions cannot be extracted on cause and influence, as the researchers pointed out.

For more health articles, visit www.foxnews.com/health

They also admitted that because the study was retroactively, they were unable to calculate the dose or duration of the Japabin.

The researchers added that the results “support the need for accurate monitoring of the adult patients described to assess the potential cognitive decline.”